Abstract:Vascular, Ahead of Print. ObjectiveThe determination of clinico-surgical predictors of carotid body tumour (CBT) metastasizing and/or recurrence.MethodsPatients with CBT but without a history of its previous treatment who had received inpatient medical aid at a tertiary surgical centre during the period 2011–2021 were retrospectively reviewed to obtain baseline data. Primary endpoints of the study were CBT metastasizing and/or local recurrence after radical surgery (composite endpoint) and overall survival. Secondary endpoint of the study was primary patency of carotid arteries that had been repaired/reconstructed as a result of CBT removal. Suspected predictors of CBT metastasizing/recurrence were young age of CBT onset, positive family history, multifocal paraganglioma, Shamblin type III CBT, carotid bifurcation and/or internal carotid artery (ICA) reconstruction as a result of CBT excision. To detect CBT metastasizing/recurrence, prospective imaging-based whole-body screening was suggested to patients.ResultsFifty-three patients met the eligibility criteria. The overall survival rate was 100% at a median follow-up time of 68 months (interquartile range [IQR] 27‒104.5 months). The primary patency of repaired carotid arteries (n = 9) was 88.9% at a median follow-up time of 99 months (IQR 15.5‒116.5 months). Thirty-nine patients underwent the prospective whole-body screening. Eight (20.5%) patients were diagnosed with metastatic disease (n = 6) or local recurrence (n = 2). Patients with CBT metastasizing/recurrence were younger at age of CBT onset (p = .011), more frequently had Shamblin type III CBT (p = .004) and the necessity for carotid artery repair/reconstruction (p = .041) than patients without metastasizing/recurrence. These two groups were similar in terms of gender (p = .682), the prevalence of multifocal paraganglioma (p = .167) and positive family history (p = .180). Only the belonging of a CBT to Shamblin type III was defined as a statistically significant predictor of CBT metastasizing/recurrence in both univariable and multivariable binary logistic regression analyses (odds ratio 30; 95% confidence interval: 2.649–339.739; p = .006 and odds ratio 75.409; 95% confidence interval: 1.082–5254.557; p = .046, respectively). Multifocal paraganglioma as a predictor exhibited a strong tendency towards statistical significance (p = .09 and p = .072, respectively). Other suspected predictors didn't reach the level of statistical significance either in univariable (p = .151 for positive family history) or in multivariable (p = .211 for age of CBT onset; p = .734 for carotid artery reconstruction/repair) binary logistic regression analyses.ConclusionShamblin type III CBT has high potential for metastasizing and recurrence. Patients with Shamblin type III CBT and/or multifocal paraganglioma should be considered for genetic testing as well as preoperative whole-body radiological imaging and long-term postoperative whole-body imaging-based follow-up.

Surgical and Histopathological Results in Carotid Body Tumors

CAR 10. Surgical Outcomes of Carotid Body Tumor Mainly With Shamblin III and Related Factors of Malignancy

Carotid body tumor: characteristics and surgical outcome

Surgical Outcomes and Factors Associated with Malignancy in Carotid Body Tumors.

Long-Term Surgical Outcomes of Carotid Body Tumors with Pathological Fibrosis: A Cohort Study

Long-term follow up outcomes of surgical resection of Shamblin Ⅱ/Ⅲ carotid body tumor: a single center analysis

Association of Complications During and After Carotid Body Tumor Resection with Tumor Size and Distance to the Base of Skull

Surgical treatment of carotid body tumour and postoperative complications

Diagnosis and Outcomes of Surgical Treatment of Carotid Bifurcation Tumors.

Preoperative Angiography and Transarterial Embolization in the Management of Carotid Body Tumor: A Single-Center, 10-Year Experience

New predictors of complications in carotid body tumor resection

Long-term results of carotid body tumours surgery and predictive analytics on metastatic disease and recurrence

Retrospective, Multicenter Study of Surgical Treatment for Carotid Body Tumors with or Without Preoperative Embolization

The Role of CT Angiography to Predict the Shamblin Group in Carotid Body Tumors

Prevalence, characteristics, evaluation, and management of carotid body tumors: Systematic analysis based on available evidence

Carotid Body Tumor and Surgical Treatment

Carotid body tumor contemporary management in a high-volume center

Surgical Treatment of Carotid Body Tumors

Postoperative Blood Pressure and Heart Rate Alterations After Carotid Body Tumor Excision: A Retrospective Study of 108 Cases

Prognostic Analysis of Management on 111 Cases of Carotid Body Tumors

Clinical Characteristics and Surgical Outcomes of Carotid Body Tumors: Data from the Carotid Paraganglioma Cooperative International Registry (CAPACITY) Group